Overdiagnosis in low-dose computed tomography screening for lung cancer.
Overdiagnosis in low-dose computed tomography screening for lung cancer.
E. Patz,P. Pinsky,6 Authors,D. Aberle
2014 · DOI: 10.1001/jamainternmed.2013.12738
JAMA Internal Medicine · 718 Citations
TLDR
More than 18% of all lung cancers detected by LDCT in the NLST seem to be indolent, and overdiagnosis should be considered when describing the risks of LDCT screening for lung cancer.